Optiver Holding
ADMA icon

Optiver Holding’s ADMA Biologics ADMA Stock Holding History

Optiver Holding’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.92K Buy
+946
New +$8.62K ﹤0.01% 1802
2025
Q4 		– Sell
-640
Closed -$9.38K – 2448
2025
Q3 		$9.38K Buy
640
+638
+31,900% +$10.9K ﹤0.01% 1341
2025
Q2 		$36 Sell
2
-43
-96% -$877 ﹤0.01% 1429
2025
Q1 		$893 Sell
45
-300
-87% -$5.19K ﹤0.01% 1286
2024
Q4 		$5.92K Buy
+345
New +$6.49K ﹤0.01% 838
2024
Q3 		– Sell
-2,156
Closed -$24.1K – 938
2024
Q2 		$24.1K Buy
+2,156
New +$18.1K ﹤0.01% 625

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Optiver Holding's ADMA Position: Q2 2026 in Review

Optiver Holding opened a new position in ADMA Biologics (ADMA) in Q2 2026: 946 shares worth $7.92K. The stake represents ﹤0.01% of the portfolio and ranks #1802 among its holdings. This is a return to the name: Optiver Holding previously reported a position in ADMA as recently as Q3 2025.

Optiver Holding first reported a position in ADMA in Q2 2024 and has held it in 6 quarters since. The position peaked at $24.1K in Q2 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Optiver Holding held 946 shares of ADMA Biologics worth $7.92K as of Q2 2026.
  • ADMA Biologics was a new Optiver Holding position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1802 holding.
  • Optiver Holding first reported a position in ADMA Biologics in Q2 2024 and has held it in 6 quarters since.
  • Optiver Holding's ADMA Biologics position peaked at $24.1K in Q2 2024.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.